Mylan

Ian Read and James Kilts offer strong experience to support long-term value creation Pfizer and Mylan announced that Ian Read…

Expanded capacity will enable greater patient access globally

Formed through a combination of two complementary businesses, Viatris will unite Upjohn’s strong leadership position in China and…

Biocon Biologics debuts on the ASIA IP ELITE 2019 list

Novartis's biosimilar, called Ziextenzo, is aimed at helping cancer patients boost infection-fighting white blood cells during…

Mylan will be in a position to launch the product in India soon after receiving approvals from DCGI," Mylan's Global President and…

Currently Mylan has 21 facilities and 15,000 employees working in India Multinational drug company Mylan will invest $1 billion…

The second eribulin brand in India, teceris aimed at expanding access to metastatic breast cancer patients in India

The second patent cliff is around the corner, as patents for branded molecules with cumulative global sales of over $ 251 billion…

FDD Conclave, a one-of-its-kind platform for formulation development and drug delivery professionals, is a thought leadership…